Loading stock…

Ypsomed Holding AG (YPSN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Ypsomed Holding AG

YPSNMarket cap $5.73BPrice $436.1

Country🇨🇭Switzerland

SectorHealthcare

IndustryHealthcare Equipment

Makes injection pens and pump systems that let millions of diabetics self-administer insulin at home. Ypsomed's devices are hidden inside products from major pharma brands worldwide, quietly powering a market most patients never realize it dominates.

In Bastion Portfolios?

52W Return+11%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+19%9

Revenue Forecast

Rev CAGR (1y)-8%1

Rev CAGR (3y)+7%5

Rev CAGR (5y)+9%7

Earnings Forecast

EPS Growth Y+1-21%2

EPS Growth Y+2+11%7

EPS Growth Y+3+17%8

Quality

Margins

EBIT Margin36%9

Net Income Margin30%9

Free Cash Flow Margin2%3

Debt

Net Debt/EBITDA0.76

Efficiency

ROE31%9

ROA17%10

Earnings Stability88

GEAR+AVERAGE61

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)272

P/E Ratio (Forward 3y)213

P/BV6.43

EV Multiples

EV/EBITDA Fwd173

EV/EBIT Fwd233

Yield

Free Cash Flow Yield0.2%3

Dividend Yield0.7%2

Momentum

Short term

1 month return-7%4

3 month return+3%7

YTD return+12%7

Mid term

Price vs 52wHigh87%7

1 year return+10%6

Long term

3 year return+49%5

5 year return+147%8

Risk Shield

Price Risk

Beta0.94

Volatility29%7

Free Cash Flow

Free Cash Flow Margin2%3

Free Cash Flow Yield0.2%3

Quality

ROCE28%10

Earnings Stability88

Net Debt/EBITDA0.76

02Growth

Is it actually growing, and how fast?

YPSNYpsomed Holding

Revenue FY26$914M

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+19%9

Revenue, next 1Y-8%1

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-21%2

EPS growth, FY28E+11%7

EPS growth, FY29E+17%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 19%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 19%/yr over the last 3 years; forecasts see it cooling to 7%/yr.

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 7%/yr). One year dips: EPS falls 21% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

YPSNYpsomed Holding

Total return Current141%

Price return Current129%

MOMENTUM RATING↗

AVERAGE62 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return+3%7

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+10%6

3-year return+49%5

5-year return+147%8

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +49% over three years and +147% over five, ahead of 60% of the market.

It's up 10% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+3%) and so far this year (+12%).

WATCH

Returns sit at the market level over the past month (-7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Ypsomed Holding AG. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

YPSNYpsomed Holding

Revenue FY26$914M

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+19%9

Revenue, next 1Y-8%1

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-21%2

EPS growth, FY28E+11%7

EPS growth, FY29E+17%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 19%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 19%/yr over the last 3 years; forecasts see it cooling to 7%/yr.

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 7%/yr). One year dips: EPS falls 21% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

YPSNYpsomed Holding

Total return Current141%

Price return Current129%

MOMENTUM RATING↗

AVERAGE62 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return+3%7

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+10%6

3-year return+49%5

5-year return+147%8

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +49% over three years and +147% over five, ahead of 60% of the market.

It's up 10% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+3%) and so far this year (+12%).

WATCH

Returns sit at the market level over the past month (-7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Ypsomed Holding AG. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community